|
|
|
Insider
Information: |
Ketchum Steven B |
Relationship: |
|
City: |
Palo Alto |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
742,979 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$495,222 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
742,979 |
|
|
Total
Value |
$495,222 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Viracta Therapeutics Ord Shs |
VIRX |
Director |
2015-07-24 |
84,259 |
2010-06-30 |
0 |
Premium* |
|
Amarin Corp Plc |
AMRN |
|
2024-01-31 |
658,720 |
2015-01-31 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
132 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 6
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
|
2020-12-31 |
4 |
D |
$5.23 |
$7,876 |
D/D |
(1,506) |
531,504 |
0 |
- |
|
VIRX |
Viracta Therapeutics Ord ... |
Sr. Vice President, R & D |
|
2011-02-28 |
4 |
D |
$2.10 |
$9,284 |
D/D |
(4,421) |
68,500 |
0 |
- |
|
AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
|
2020-07-31 |
4 |
D |
$6.59 |
$9,938 |
D/D |
(1,508) |
523,756 |
0 |
- |
|
AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
|
2020-06-30 |
4 |
D |
$6.72 |
$10,120 |
D/D |
(1,506) |
522,210 |
0 |
- |
|
AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
|
2020-05-29 |
4 |
D |
$6.86 |
$10,331 |
D/D |
(1,506) |
520,662 |
0 |
- |
|
AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
|
2022-07-29 |
4 |
D |
$1.33 |
$10,881 |
D/D |
(8,181) |
512,615 |
0 |
- |
|
AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
|
2020-08-31 |
4 |
D |
$7.36 |
$11,084 |
D/D |
(1,506) |
525,304 |
0 |
- |
|
AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
|
2018-01-11 |
4 |
AS |
$4.40 |
$11,493 |
D/D |
(2,612) |
141,797 |
0 |
- |
|
AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
|
2020-04-30 |
4 |
D |
$8.26 |
$12,440 |
D/D |
(1,506) |
519,112 |
0 |
- |
|
AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
|
2021-07-30 |
4 |
D |
$4.14 |
$12,946 |
D/D |
(3,127) |
452,160 |
0 |
- |
|
AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
|
2023-07-31 |
4 |
D |
$1.19 |
$13,998 |
D/D |
(11,763) |
600,231 |
0 |
- |
|
AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
|
2021-06-30 |
4 |
D |
$4.48 |
$14,009 |
D/D |
(3,127) |
449,179 |
0 |
- |
|
AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
|
2021-05-28 |
4 |
D |
$4.54 |
$14,201 |
D/D |
(3,128) |
446,198 |
0 |
- |
|
AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
|
2023-02-28 |
4 |
D |
$2.03 |
$15,668 |
D/D |
(7,718) |
588,111 |
0 |
- |
|
AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
|
2021-04-30 |
4 |
D |
$5.24 |
$16,391 |
D/D |
(3,128) |
443,214 |
0 |
- |
|
AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
|
2022-01-31 |
4 |
D |
$3.36 |
$17,207 |
D/D |
(5,121) |
486,087 |
0 |
- |
|
AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
|
2021-08-31 |
4 |
D |
$5.54 |
$17,324 |
D/D |
(3,127) |
455,141 |
0 |
- |
|
AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
|
2022-02-28 |
4 |
D |
$3.27 |
$18,011 |
D/D |
(5,508) |
496,912 |
0 |
- |
|
AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
|
2022-12-30 |
4 |
D |
$1.21 |
$19,797 |
D/D |
(16,361) |
544,021 |
0 |
- |
|
AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
|
2021-03-31 |
4 |
D |
$6.37 |
$19,925 |
D/D |
(3,128) |
440,230 |
0 |
- |
|
AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
|
2020-03-31 |
4 |
D |
$13.58 |
$20,451 |
D/D |
(1,506) |
517,562 |
0 |
- |
|
AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
|
2023-12-29 |
4 |
A |
$0.87 |
$20,467 |
D/D |
23,525 |
590,341 |
0 |
- |
|
VIRX |
Viracta Therapeutics Ord ... |
Director |
|
2013-11-08 |
4 |
OE |
$2.09 |
$21,951 |
D/D |
10,503 |
84,464 |
0 |
- |
|
VIRX |
Viracta Therapeutics Ord ... |
Director |
|
2015-07-24 |
4 |
OE |
$1.32 |
$21,986 |
D/D |
16,656 |
86,378 |
0 |
- |
|
VIRX |
Viracta Therapeutics Ord ... |
Director |
|
2015-07-24 |
4 |
S |
$3.46 |
$21,989 |
D/D |
(6,358) |
84,259 |
0 |
- |
|
132 Records found
|
|
Page 3 of 6 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|